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Head and neck cancers arise from the epithelium of the upper
airway and digestive tracts. The term incorporates cancers of the
mouth, larynx, throat, nose, ears, salivary glands, thyroid or neck,
which together make up about 6% of all cancers in the United
Kingdom and half a million cases worldwide per annum. The UK
incidence is 8–12 (depending on region) cases per 100000
population per annum, or about 6500 new cases. They are more
common in men than women, and the dominant aetiological
associations are with tobacco and alcohol consumption.
Cancer of the larynx is the most common type of head and neck
cancer in most western countries. Coleman et al (2004) reported
5666 cases in men in the United Kingdom in the 3-year period
between 1996 and 1999. These authors also described a 3.3%
improvement in survival every 5 years over the period of study
between 1986–1999 and 1996–1999. Most UK patients present
early, as even a small growth on the vocal cords (73% occur here)
causes a discernible change in voice. However, around 30% present
at a later stage, either because voice change was ignored or because
of lack of recognition of the much vaguer symptoms associated
with tumours beyond the vocal cords.
Treatments include surgery, radiation, chemotherapy or combi-
nations of these three. According to the second DAHNO report
(Wight, 2008), 63% of early vocal cord cancers still received
radiotherapy in the United Kingdom in 2006, although endoscopic
resection techniques had significantly gained popularity since the
first report (for 2004) when the figure for radiotherapy was 77%. In
2006, 67 of 69 early vocal cord cancer patients reported to have had
surgery were treated endoscopically. In the same report, 61% of
advanced lesions were treated with a combination of surgery and
radiotherapy.
CHANGES IN PRACTICE BETWEEN 1985 AND 2001
Significant advances in the period 1985–2001 included improve-
ments in diagnostic techniques: routine use of the flexible
laryngoscope in ENT outpatients, advances in computed tomo-
graphy and magnetic resonance imaging. Therapeutic advances
include the more widespread acceptance of combined modality
therapy with surgery and the application of postoperative radiation
for advanced laryngeal tumours. As demonstrated by the DAHNO
audits (Wight, 2008), the European enthusiasm for endoscopic
excision of laryngeal cancer has gradually spread to the United
Kingdom over the last 5 years, though it is still largely restricted to
early-stage disease. The use of selective neck dissection in
combination with laryngectomy may have reduced loco-regional
recurrence rates, but the biggest improvements in surgical
treatment are in the area of rehabilitation and particularly the
use of prosthetic voice valves. The widespread application of CT
planning has significantly improved the quality of radiotherapy
delivery for head and neck cancer. Supported by some large recent
trials, concomitant chemoradiation therapy is increasingly used
for stage III and IV disease, and postoperatively in those with poor
prognostic features and who are fit enough for this arduous
combination. Despite the increasingly widespread use of chemo-
radiation treatment for intermediate and advanced laryngeal
cancer, there is still work to be done to demonstrate that the
long-term functional outcomes of voice and swallowing are better
than those achieved by surgery.
Given this range of significant changes in practice over the last
10 years, there are reasons to believe that the reported increase in
survival of 3.3% every 5 years is real. Support for the data of
Coleman et al comes from recently published audit data showing a
statistically significant 12.6% improvement in 2-year survival
between cohorts of patients in the south and west of England
between 1997 and 2000 (Birchall et al, 2004).
It is, of course, difficult from these data to identify any particular
change in practise that might be the major cause of such
improvement in survival. Comparison of detailed Scottish and
south and west of England cohorts (MacKenzie and Birchall,
unpublished data), totalling 4000 head and neck cancer patients
over the same 1998–2002 period showed wide differences in care
processes for laryngeal cancer between the two regions, but this did
not appear to influence survival. The cure rates for early-stage
larynx cancer are already greater than 90% so it is unlikely that
improvements in this subset can be responsible for the improve-
ment seen overall. Therefore, we hypothesise that any increase in
survival is more likely to devolve from those with advanced disease.
Improved standards of diagnosis, particularly the use of
Hopkins’ rod telescopes as part of panendoscopy, cross-sectional
imaging with CT or MRI, and fine needle aspiration, are likely to
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larynx cancer. These methods allow the identification of more
advanced stage disease at the primary site or in cervical lymph
node metastases, possibly resulting in ‘stage shift’, with an
apparent improvement when none has really taken place (Feinstein
et al, 1985) Finally, the increased use of specialist multidisciplinary
team working, and concentration of care in fewer centres, may
have led to better treatment decision making and consequently
better outcomes (Bradley et al, 2005; Rachet et al, 2008).
THE INCREASING SOCIO-ECONOMIC GAP
Rachet et al (2008) describe how difference between most and least
deprived groups increased more for laryngeal cancer than for any
other cancer in men, and more quickly (almost 4% every 5 years),
between 1985 and 2001, reaching 17% for the 1996–1999 cohort. In
fact, the most affluent groups accounted for nearly all of the overall
increase in survival by themselves.
As other smoking-related cancers were analysed using identical
techniques in the present series of reports, it is unlikely that this is
either a methodological artefact, or due to some systematic effect
of changes in smoking patterns. We are therefore left to consider
those factors that are uniquely different about laryngeal cancer and
how socio-economic status may affect them.
The care pathway for laryngeal cancer is especially complex;
therefore better continuity of care, from GP onwards, may
play a part. Better educated people may have better contact with
GP’s in the first place (Reid and Rozier, 2006) and be better
able to negotiate their way through a complex and lengthy pathway
of diagnosis, treatment and rehabilitation. Head and neck
cancer care, for all the circumstantial evidence in favour of
centralisation, remains the most disseminated of all cancers in the
United Kingdom. As access to information (and use of the
internet particularly) became more widespread during the 1990s,
it may be that more affluent patients were better able to
choose their hospitals and doctors and to travel to bigger centres.
The other unique aspect of laryngeal cancer is that it
presents, generally, with a change in voice. Some occupations,
professional voice users, may be more sensitive to the symptoms of
an early cancer and this may lead to earlier presentation.
The remarkable socio-economic effect is not just of passing
interest, however. By studying how it really does influence survival
for this group, we may learn some crucial lessons about how
we organise our care for laryngeal cancer patients in the
United Kingdom.
CONCLUSIONS
The observed improvements in survival for laryngeal cancer
over the studied period probably are real, and multifactorial in
origin. Improvements in accuracy of diagnosis and staging
have certainly occurred. Major changes in individual treatment
approaches, better team working between surgeons and
radiotherapists, and the increased use of combined modality
therapy in advanced stage disease are all likely to have played
a part. However, the concentration of this improvement in the
more affluent groups only suggests some more fundamental effects
on survival, which may require substantial (and urgent) changes in
the way the diagnostic and care pathways for laryngeal cancer are
constructed. Further, prospective studies to examine the contribu-
tions of each of these factors are required to optimise management
strategies and patterns of care for the future.
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